Marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

Posted by Zander Henry on Aug-22-2018

1. The vision of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

The vision of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company is to be the leading quality service and product provider for customers. Being the best and the leading player means that AstraZeneca Plc Corporate Governance at a Pharmaceutical Company marketing strategy and operations focus on:

• Providing high quality of products and services
• Providing value to customers
• Concentrate on building customer experience

2. The mission of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

AstraZeneca Plc Corporate Governance at a Pharmaceutical Company marketing strategy is grounded in its mission. The mission for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company is to be the favorite brand of the customers. This mission is essential for the marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company as it focuses on all operations and marketing activities in the direction of:

• Consumer centrism
• Using research to understand and influence consumers

3. Brand Equity of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

Understanding and knowing the brand equity is vital for directing and giving meaning to the marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company. The knowledge of brand equity will help in shaping AstraZeneca Plc Corporate Governance at a Pharmaceutical Company marketing strategy effectively – thereby facilitating the growth of business for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company.

3.1. Brand awareness

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has high brand awareness because of international operations
• The company focuses on higher budget allocation in the country of origin
• Each market for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has modified marketing and strategic directives and plans

3.2. Brand association

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company is directly associated with the brand name and product category
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has a broad product portfolio
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company is associated with promising and delivering quality and innovative products
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company is also associated with excellent customer service

3.3. Brand loyalty

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has been successful at gaining high consumer loyalty because of unique and influential marketing strategy
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has a global customer base
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company keeps adding value addition to the products and product portfolio to keep consumers engaged

3.4. Brand asset

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has a substantial brand value
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also enjoys the high financial worth
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company focuses on building a reliable and robust employee base

3.5. Brand element

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company uses the brand element as a means of competitive advantage
• Uses adaptability in product, services, and marketing to meet different cultural demands

4. Situational Analysis of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

The situational analysis will help in developing the marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company by conducting a thorough market analysis. This market analysis will aid in understanding the compatibility between external opportunities and other factors, and internal strengths – to be used to maximize the marketing influence of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company.

4.1. SWOT

4.1.1. Strengths

AstraZeneca Plc Corporate Governance at a Pharmaceutical Company marketing strategy can benefit from the following internal advantages:

• Strong brand image
• Global distribution network
• Investment in market research
• Innovation

4.1.2. Weakness

AstraZeneca Plc Corporate Governance at a Pharmaceutical Company faces challenges in marketing strategy because of the following weakness:

• Slow organizational processes
• High product prices

4.1.3. Opportunity

AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has the following possibilities of business growth:

• Green lifestyles
• Regional expansion
• Diversification

4.1.4. Threats

AstraZeneca Plc Corporate Governance at a Pharmaceutical Company faces business threats because of the following factors:

• Increased competition
• Increased imitation

4.2. PESTEL

4.2.1. Political

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company operates I markets with political stability
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has funding support from the government for small businesses

4.2.2. Economic

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company enjoys high sales because of higher GDP
• Lower interest rates make business expansion and loaning easier for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company
• Low inflation strengthens the financial position of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

4.2.3. Social

• Higher education and awareness increases sales of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company predict
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company focuses on understanding consumers and fulfilling their demands through its offerings

4.2.4. Environmental

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has an active CSR program
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company ensures environmental safety in all its operations

4.2.5. Legal

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company is aware of local and global laws of business and human resource management
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company abides by all statutes – especially labour law, discrimination law, and employee safety laws

4.3. Porter’s Five Forces

4.3.1. Threat of substitutes

• High risk of replacements
• Substitutes offer similar products at low prices

4.3.2. The threat of new entrants

• New entrants need high financial investment
• New entrants need updated technology for keeping par with industry progress

4.3.3. Bargaining power of buyers

• Sales made to end consumer directly
• Stocking of products at retailers, as well as own-controlled retail outlets

4.3.4. Bargaining power of suppliers

• Multiple suppliers of raw materials
• Suppliers are chosen after careful inspection, and through contracts

4.3.5. Industry rivalry

• High industry rivalry
• Players offer similar products
• Players compete through marketing to influence consumers

5. Marketing Objectives for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company: The Marketing Strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

AstraZeneca Plc Corporate Governance at a Pharmaceutical Company marketing strategy has the following objectives for the current financial year:

5.1. Increased market penetration

• Increase top of mind recall for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company brand and products by 30%
• Increase sales for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company by 40% by the third quarter of the financial year
• Achieve a trial rate for new products of 10% during the first quarter of the launch
• Increase consumption rate of existing products by 45% during the current financial year

5.2. Enhanced brand recognition

• Increase top of mind recall by 65% during the current fiscal year
• Increase brand recognition by 80% during the first two quarters of the current financial year

5.3. Increased use of digital marketing

• Acquire 25,000 new online customers during the financial year
• Increase website traffic through using blogging and email tactics effectively by 505 during the first two quarters of the year
• Acquire 65,000 likes on the official Facebook page of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company during the first quarter of the financial year

5.4. Retail Growth

• Contract with five more leading supermarkets in the first quarter of the year to stock product at eye level shelving
• Contract with two leading online retail sites – eBay and Amazon – to stock our products, and increase accessibility for consumers globally by the second quarter of the financial year

6. Segmentation of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

AstraZeneca Plc Corporate Governance at a Pharmaceutical Company marketing strategy uses different means of segmentation to reach an increase in market penetration.

6.1. Demographic segmentation

6.1.1. Age

AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has consumers of age groups

• 20-45 years
• 45-60 years

6.1.2. Gender

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has a broad product portfolio for both males and females

6.1.3. Life-cycle stage

Consumers for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company, according to the marketing strategy, are in the following various life cycle stages:

• Single students
• Single graduates
• Single people living at home/not living at home
• Young couples without children
• Married couples with one to four children – all at home
• Married couples with one or two children in college
• Old married couples with an empty nest

6.1.4. Occupation

The marketing strategy devises the following occupations for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company consumers:

• Professionals
• Students
• House makers

6.2. Psychographic segmentation

6.2.1. Social class

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company focuses on segments of middle-upper and upper social classes

6.2.2. Lifestyle

AstraZeneca Plc Corporate Governance at a Pharmaceutical Company consumer segments have the following lifestyle characteristics:

• They aspire towards a better and higher living standard
• They want to be successful – professionally and socially
• They are not hesitant to try new things, products and services in life
• They are confident in their behaviour and attitude
• They are mainstreamers in their fields

6.3. Geographic segmentation

6.3.1. Region

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has operations spread across the western developed countries such as America, the united kingdom, and the Netherlands
• It also has operations in emerging markets such as Brazil, India, and China

6.3.2. Density

• The focus of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company remains on the urban part of the population

6.4. Behavioural segmentation

6.4.1. Personality

The marketing strategy defines personality characteristics for the consumers of the brand of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company, such as:

• Determined
• Confident
• Ambitious
• Hardworking

6.4.2. Usage frequency

• The consumer segments for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company are regular and frequent users of the product

6.4.3. Benefits sought

• Consumers seek functional benefits
• The focus, however, is more on the emotional benefits reaped from the consumption of the brand

6.4.4. Degree of loyalty

• Consumers are very loyal
• Have an emotional attachment with the brand

7. Targeting of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company Positioning of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

The marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company targets consumer groups based on segmentation as follows:

7.1. Target market

• The target market for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company is from middle to upper class
• The target market is ambitious and desires to purchase high-end consumer products
• This target market also seeks affordability
• To meet target market expectations, the AstraZeneca Plc Corporate Governance at a Pharmaceutical Company focuses on quality control

7.2. Mass marketing

• The marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company focuses on mass marketing
• This also requires unique marketing designs and product promotion programs
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company makes use of one strategy to influence all segments

7.3. Undifferentiated marketing strategy

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company does not differentiate between market segments
• It uses a single marketing strategy to target all segments and consumer groups
• Based on this, AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also created the marketing mix under the marketing strategy as a singular one for the whole market – regardless of the segmentation divides.

7.4. Focus on quality

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has created, developed, and maintained a brand that satisfies all consumers under the undifferentiated marketing strategy and mass marketing
• No compromise on quality has been made in the broad product portfolio
• To ensure the influence of a single marketing strategy, the AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has also adopted a consumer-centric approach in its overall marketing strategy and operations as well
• This was used for targeting strategy as well as for maintaining growth

8. Company Competitive Advantage in the marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

The marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company stands out from the clutter and competition. AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has also achieved a sustainable competitive advantage in its marketing strategy. This is because of the following factors that AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has utilized:

8.1. Cost-effectiveness

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company focuses on reaching consumers effectively rather than grandeur
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company focuses on developing an integrated marketing approach
• The use of digital marketing efficiently and expertly has helped the company reach a wider audience at a lower cost
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has in-house copywriters for marketing campaigns which also helps in controlling costs
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also focuses efforts on ground activities – which are less expensive than commercial marketing tactics

8.2. Innovation

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has stayed updated with latest developments in marketing research and marketing knowledge
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company makes use of new and innovative tactics to reach its target consumers
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also employs top of the field marketers to facilitate its marketing strategy and promotional campaigns
• Each marketing campaign launched by AstraZeneca Plc Corporate Governance at a Pharmaceutical Company is effective catchier and more influential than the previous one

8.3. Strong market research and consumer understanding grounded

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company marketing strategy is strongly grounded in consumer and market research
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company makes informed marketing campaigns and goals based on consumers’ behavioural feedback
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also incorporates consumer feedback in its marketing strategy
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company marketing strategy is based on market trends, and consumer needs and wants

8.4. Making effective use of emotional appeals

• Consumers’ emotional needs strongly influence all marketing objectives and marketing goals set by AstraZeneca Plc Corporate Governance at a Pharmaceutical Company
• In addition to fulfilling functional needs, AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also tries to fulfil the emotional and psychological needs of the consumer
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company tries to build a strong emotional bond with the consumer, which also results in high consumer loyalty

9. Distribution Strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

AstraZeneca Plc Corporate Governance at a Pharmaceutical Company marketing strategy highlights the use of the following distribution strategy to maximize reach and accessibility for consumers.

9.1. Intensive distribution strategy

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company makes use of intensive distribution strategy because it is mass marketing
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company’s marketing strategy is based on undifferentiated segments, and thus an intensive distribution strategy allows high penetration and reaches in the overall market
• With the use of the intensive distribution, AstraZeneca Plc Corporate Governance at a Pharmaceutical Company tries to maximise its coverage of the markets where it's present
• For achieving the intensive strategy, the company uses hardcore 360-degree integrated marketing strategy and campaign to reach all consumers, across all segments in the market.

9.2. Direct distribution strategy

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company uses direct distribution country of origin as well as in locations where it has subsidiary operations
• The AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also makes use of modern retailing channels
• Also, AstraZeneca Plc Corporate Governance at a Pharmaceutical Company makes use of e-commerce and makes a sale through online retailers, as well as through the company website
• Direct distributions have allowed AstraZeneca Plc Corporate Governance at a Pharmaceutical Company to increase market penetration and accessibility for consumers

9.3. Indirect distribution strategy

• This strategy is largely used for offshore operations where the AstraZeneca Plc Corporate Governance at a Pharmaceutical Company does not have a subsidiary
• In these offshore locations, AstraZeneca Plc Corporate Governance at a Pharmaceutical Company largely works through the export model
• This makes use of several intermediaries in between, before the product by AstraZeneca Plc Corporate Governance at a Pharmaceutical Company reaches the target consumers
• Intermediaries for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company include not only the end retail outlets, but also sales agents, retail agents, and distribution agents in offshore locations

9.4. Selective distribution strategy

• For some products of its portfolio which are premium in nature, AstraZeneca Plc Corporate Governance at a Pharmaceutical Company makes use of selective distribution channel
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has maintained a few outlets in the country of origin, and in selected offshore markets for these products
• These placements and locations are chosen based on the niche market that AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has for its premium products
• These locations, placements, and marketing strategy helps make the company’s product selectively, but readily accessible for its niche target audience

10. Competition Analysis in the marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

The industry in which AstraZeneca Plc Corporate Governance at a Pharmaceutical Company operates is very responsive to market and consumer trends. AstraZeneca Plc Corporate Governance at a Pharmaceutical Company, therefore, needs to be vigilant in its market strategy towards competition – to make sure that it maintains its competitive advantage.

10.1. Strategic Group Analysis

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company competes with direct and close competition based on quality and price
• Consumers choose between different companies from the industry based on their functional offering
• Consumers have progressively evolved to strengthen loyalty and form an emotional bond with products that they consume
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also competes, thereby, with close competition for building stronger brand image, increasing consume loyalty, and for forming strong emotional ties with the consumer

10.2. Industry rivalry

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company experiences high industry rivalry
• The barriers to entry for the industry are low, and new entrants gain easy access in the industry
• The number of local as well as global players is increasing

11. Marketing mix of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

The marketing mix for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company as per the marketing strategy is the following:

11.1. Product

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has a broad product portfolio
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company provides mass marketed products for all segments across the market undifferentiated
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also provides some selected, premium products to niche customer groups
• All products in the portfolio consistently maintain high quality
• All products are tailored to meet consumer specifications, demands and needs across different regional markets
• The AstraZeneca Plc Corporate Governance at a Pharmaceutical Company maintains a high focus on innovation in products and introduces new products frequently to keep the consumers engaged

11.2. Place

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company wants to have a close, emotional and personal relationship with its consumers
• The company maintains high control in its distribution strategies – especially through direct distribution strategy
• The company has a presence in leading supermarkets
• The AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also has company-operated stores in malls, and otherwise to make products accessible to consumers easily
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also makes use of e-commerce to increase penetration and sales

11.3. Price

• The AstraZeneca Plc Corporate Governance at a Pharmaceutical Company prices its products so that its target consumers can afford it easily
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company uses relative pricing strategy for its products
• The price of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company’s products include not only the high quality raw materials and value additions but also the enhanced customer experience they deliver
• The company’s pricing strategy allows it to enjoy stable revenue and profit growth

11.4. Promotion

• The AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has a high budget allocated towards marketing activities
• The AstraZeneca Plc Corporate Governance at a Pharmaceutical Company invests substantially in digital marketing activities to reap high and effective results
• Use of digital marketing has also allowed AstraZeneca Plc Corporate Governance at a Pharmaceutical Company marketing strategy to cap costs and expenses
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also takes part in direct consumer engagement through on-ground activities where the company initiates trials
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also invests in traditional media channels to reach maximum consumers in the market

11.5. People

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company has a large workforce across different companies
• This workforce is continually trained to become experts in their respective fields of operations
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company hires without discrimination
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company ensures that its employees remain motivated through building an inspirational and creative organizational culture
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company focuses on also building and maintaining organizational commitment and loyalty in its employees

11.6. Process

• All activities at AstraZeneca Plc Corporate Governance at a Pharmaceutical Company - from raw material procurement to the final sale to the end consumer - undergo systematic processes
• The processes at AstraZeneca Plc Corporate Governance at a Pharmaceutical Company are well defined, and well communicated to all employees
• All employees are trained to follow the processes internally to ensure consistently high quality as well as timely production and deliveries
• The systematic processes also ensure a smooth running of operations at the AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

11.7. Physical evidence

• The physical evidence for AstraZeneca Plc Corporate Governance at a Pharmaceutical Company includes the company logo, company store designs, and the product packaging
• Satisfied and excited customers in the retail spaces of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company, as well as during product consumption create a bubbling and an inviting atmosphere
• The e-commerce website for retail by AstraZeneca Plc Corporate Governance at a Pharmaceutical Company is also designed with a friendly customer interface to allow maximum interaction with the brand
• The store designs created by AstraZeneca Plc Corporate Governance at a Pharmaceutical Company for its retail space allow consumers maximum interaction with the products directly.

12. Promotional tactics for the marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

12.1. Digital marketing

• The company uses social media for reaching consumers effectively
• The AstraZeneca Plc Corporate Governance at a Pharmaceutical Company interacts with the consumers directly, and engages with them, answers their queries and takes their feedback
• The company also shares information and build relationships with consumers through digital marketing
• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company also makes use of blogging, emails, and content creations as a means of digital marketing

12.2. Conventional marketing

• The company uses a 360-degree approach in its marketing strategy
• This means that the company makes use of traditional marketing channels as well – such as TV, magazine adverts, and out of house placements

12.3. Influencers

• For direct, on-ground engagement, the company uses influencers
• Influencers interact with consumers directly, or through their channels of communication as a means of content creation and endorsing the AstraZeneca Plc Corporate Governance at a Pharmaceutical Company brand

13. Monitoring and evaluation of the marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company

13.1. Changes in sales

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company regularly tracks its sales to identify the effectiveness of its marketing strategy
• Increase in sales reflect the success of marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company
• Sometimes, AstraZeneca Plc Corporate Governance at a Pharmaceutical Company experiences increase ins ae after some time of the launch of the marketing promotions

13.2. Surveys and focus groups

• AstraZeneca Plc Corporate Governance at a Pharmaceutical Company frequently conducts focus groups and surveys to identify its brand worth
• These methods also help the company identify brand value, brand recall, and brand recognition
• Focus groups allow AstraZeneca Plc Corporate Governance at a Pharmaceutical Company to gather feedback on its marketing strategy and helps it understand consumers better

13.3. ROI

• Effectiveness of marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company can also be seen through the revenue and profit growth
• Return on investment allows AstraZeneca Plc Corporate Governance at a Pharmaceutical Company to effective gauge the effect and influence of the marketing strategy, and measure its success

13.4. Attainment of marketing objectives

• All marketing objectives set by AstraZeneca Plc Corporate Governance at a Pharmaceutical Company are SMART
• The quantitative set against each of the marketing objective can facilitate attainment evaluation for the overall marketing strategy
• Successful and timely attainment of these marketing objectives highlight the success of the marketing strategy of AstraZeneca Plc Corporate Governance at a Pharmaceutical Company